Revance Therapeutics Inc.

NASDAQ: RVNC
Share price (1/8/25): $3.39
Market cap (1/8/25): $356 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from 8-K 33 pages Revance Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement

from 8-K 36 pages Revance Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement

from 8-K 35 pages Revance Therapeutics, Inc. Common Stock Underwriting Agreement

from 8-K 34 pages Revance Therapeutics, Inc. Common Stock Underwriting Agreement January 16, 2019 1

from 8-K 6 pages Revance Releases Second Quarter 2018 Results

from 8-K 42 pages Revance Therapeutics, Inc. Common Stock Underwriting Agreement

from 8-K 32 pages 3,250,000 Shares Revance Therapeutics, Inc. Common Stock Underwriting Agreement

from S-1/A 28 pages [—] Shares Revance Therapeutics, Inc. Common Stock Underwriting Agreement

from S-1/A 32 pages [•] Shares Revance Therapeutics, Inc. Common Stock Underwriting Agreement